Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Three-agent chat app for lonely older adults in Hong Kong

Official title: A Mechanism Randomised Controlled Trial of a Three-Agent LLM-Augmented mHealth Intervention for Late-Life Loneliness in Older Adults

Run by The University of Hong Kong · NCT07822828 · Data updated 2026-11-12

This trial tests whether a Cantonese-language smartphone chat app with three conversational companions can help reduce loneliness in adults aged 60 and older in Hong Kong, by comparing a version powered by a large language model to a version using pre-written templates.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment72 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations1 site (Hong Kong, Hong Kong SAR)
StatusRecruiting
StartedOctober 21, 2026
Main results expectedFebruary 28, 2027
Study endsFebruary 28, 2027
Registry record updatedNovember 10, 2026
Trial IDNCT07822828 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are community-dwelling Cantonese-speaking adults aged 60+ in Hong Kong who feel at least moderately lonely and can use a smartphone.

Probably not a fit

Individuals with severe cognitive or sensory impairments, active suicidality, or those already receiving formal psychiatric treatment may not benefit or may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized study, 72 Cantonese-speaking adults aged 60+ living in the community in Hong Kong with at least moderate loneliness will use a smartphone-based conversational app. Participants are randomized to receive either a hybrid arm with a language-model–generated assistant (plus memory, tone customization, reminiscence prompts, and model-created life-story chapters) or a built-in rule-based arm with the same interface and features minus the model-dependent capabilities. Both arms share the same visual design, three named companions, tools, and assessment prompts, isolating the effect of the language-model backend and related features. The study aims to determine whether the language-model–driven interactions provide added benefit over the template-based approach while controlling for interface richness and engagement. Outcomes focus on changes in loneliness and related well-being metrics collected through in-app assessments.

Why it matters

Potential benefit: If successful, participants may experience reduced loneliness and improved social connectedness through more engaging, personalized digital conversations.

How similar studies have gone: Previous studies of large language model–based conversational agents for loneliness are mostly early-stage; this trial adds a rigorous, architecturally matched comparator to isolate the model’s impact.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 60 years or above
* Self-identified Cantonese as primary language of communication
* Community-dwelling in Hong Kong (not in residential care)
* De Jong Gierveld Emotional and Social Loneliness Scale total score of 2 or above at screening, indicating at least moderate loneliness
* owns a smartphone on which the study app can be installed
* Able to demonstrate understanding of the study using the teach-back method
* Willing to provide written informed consent

Exclusion Criteria:

* Acute suicidality, defined as a PHQ-9 item 9 score above 1 with reported active intent
* Currently receiving formal psychiatric treatment
* Severe hearing or visual impairment precluding application use even with accommodation
* Self-reported diagnosis of dementia or significant cognitive impairment
* Unable to demonstrate understanding of the study using the teach-back method
* Prior participation in the pilot runs of this trial
* Another member of the same household has already registered for the study

Where it's running

  • The University of Hong Kong
    Hong Kong, Hong Kong SAR, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.